Paul Titchenell, PhD
- - -
- - -
Smilow Center for Translational Research
3400 Civic Center Blvd
Philadelphia, PA 19104
- - -
- - -
Paul Titchenell, PhD
Assistant Professor of Physiology
Other Perelman School of Medicine Affiliations
Degrees & Education
BS, Biochemistry and Molecular Biology, Dickinson College, 2008
PhD, Physiology, Pennsylvania State University, 2013
Awards & Honors
2016 Career Development Award NIDDK
2015 Rising Star in Metabolism and Diabetes University of Utah, Salt Lake City, UT
2015 Keystone Symposia Scholarship (NIDDK), J6 Diabetes and Metabolic Dysfunction, Santa Fe, NM
2013 NRSA Fellowship NIDDK
American Diabetes Association
Insulin signaling, Insulin resistance, Metabolism
My research interests are focused on the regulation of metabolism by hormones and nutrients, with a particular emphasis on the master regulators of organismal metabolism, insulin and glucose. Alterations in insulin and glucose signaling underlie metabolic disease and lead to the development of deadly vascular and neuronal complications. Through the use of various techniques encompassing molecular biology, biochemistry, metabolomics, genome-wide transcriptional techniques and whole-animal physiology, the long-term goals of my research program are to decipher the underlying mechanisms driving metabolic deregulation during disease and identify new therapies that improve metabolic control.
Matthew Gavin, Research Specialist
Natasha Jaiswal (Postdoctoral Researcher)
Jaimarie Sostre (CAMB rotation graduate student)
Rebecca Gelfer, Undergraduate Researcher
Brennan Rose, Undergraduate Researcher
Quinn William J, Wan Min, Shewale Swapnil V, Gelfer Rebecca, Rader Daniel J, Birnbaum Morris J, Titchenell Paul M: mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion. The Journal of clinical investigation 127(11): 4207-4215, Nov 2017.
Titchenell Paul M, Lazar Mitchell A, Birnbaum Morris J: Unraveling the Regulation of Hepatic Metabolism by Insulin. Trends in endocrinology and metabolism: TEM Apr 2017.
Papazyan Romeo, Sun Zheng, Kim Yong Hoon, Titchenell Paul M, Hill David A, Lu Wenyun, Damle Manashree, Wan Min, Zhang Yuxiang, Briggs Erika R, Rabinowitz Joshua D, Lazar Mitchell A: Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. Cell metabolism 24(6): 863-874, Dec 2016.
Jang Hagoon, Lee Gha Young, Selby Christopher P, Lee Gung, Jeon Yong Geun, Lee Jae Ho, Cheng Kenneth King Yip, Titchenell Paul, Birnbaum Morris J, Xu Aimin, Sancar Aziz, Kim Jae Bum: SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding. Nature communications 7: 12180, Jul 2016.
Titchenell Paul M, Quinn William J, Lu Mingjian, Chu Qingwei, Lu Wenyun, Li Changhong, Chen Helen, Monks Bobby R, Chen Julia, Rabinowitz Joshua D, Birnbaum Morris J: Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell metabolism 23(6): 1154-66, Jun 2016.
Titchenell Paul M, Chu Qingwei, Monks Bobby R, Birnbaum Morris J: Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nature communications 6: 7078, May 2015.
Perry Rachel J, Camporez João-Paulo G, Kursawe Romy, Titchenell Paul M, Zhang Dongyan, Perry Curtis J, Jurczak Michael J, Abudukadier Abulizi, Han Myoung Sook, Zhang Xian-Man, Ruan Hai-Bin, Yang Xiaoyong, Caprio Sonia, Kaech Susan M, Sul Hei Sook, Birnbaum Morris J, Davis Roger J, Cline Gary W, Petersen Kitt Falk, Shulman Gerald I: Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160(4): 745-58, Feb 2015.
Click here for a full list of publications.
(searches the National Library of Medicine's PubMed database.)